Upadacitinib is associated with sustained or improved responses across various patient-reported outcome measures at 140 weeks among those with AD.

In the real world, patients rarely navigate a single diagnosis in isolation. Most manage a complex web of overlapping conditions and long-term treatment histories, and this reality is often simplified ...

The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom progression in ...

Please provide your email address to receive an email when new articles are posted on . In business, the focus on consistent outcomes includes managing “inputs,” such as uniform materials and ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

Steven Nathan, MD, continues a discussion surrounding the patient journey in through IPF treatment. What is the potential impact of these novel treatments on disease progression, mortality, and ...

Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Providing the best patient-centered care, as measured by the individual ...

Implementation of an electronic patient-recorded outcome (ePRO) monitoring system improves patient-physician communication in cardiovascular care, according to a study published online Jan. 14 in JAMA ...

Real-world assessment of treatment-related symptoms and associated burden among African American and Caucasian patients receiving chemotherapy in the US. Impact of clinical response and AEs on ...